Professor Susan Clark Related News
What it might take to unravel the ‘lean mean machine’ that is cancer
MEDIA RELEASE:
22 Feb 2010
Garvan scientists have published a paper, online today in Nature Cell Biology, describing gene expression in a prostate cancer cell: more sweeping, more targeted and more complex than we could ever have imagined, even five years ago.
Epigenetics featured in NHMRC ‘Ten of the Best Research Projects 2009’
17 Aug 2009
The work of Garvan’s Professor Susan Clark is featured in the NHMRC (National Health and Medical Research Council) 10 of the Best Research Projects 2009 booklet, launched this morning in Canberra. Of the hundreds of research projects funded by the NHMRC each year, the booklet highlights those that best help combat some of the nation’s biggest health challenges.
A step towards finding the cancer switch
MEDIA RELEASE:
17 Jun 2009
Garvan epigeneticists describe exactly what happens to a person's DNA the moment at which a breast cancer suppressor gene is switched off - taking us one step closer towards finding ways to control the biochemical processes that 'switch on' bad genes and 'switch off' good ones.
New Australian Epigenome Alliance moves towards a Brave New World
MEDIA RELEASE:
22 Aug 2008
In the same week as the Australian Epigenome Alliance formed, Alliance member and Garvan epigenetics expert, Professor Susan Clark, was the Australian contributor to a Nature article about the global taskforce taking shape for the human epigenome project. According to Professor Clark, "we have the words, and now we need the syntax or grammar to make sense of them."
Garvan cancer researcher wins Premier's Award
18 Jun 2008
Garvan researcher Rebecca Hinshelwood received the highly coveted $10,000 Premier’s Award for Outstanding Cancer Research Scholar at a gala ceremony last month. The award, from the Cancer Institute of NSW, is a form of educational scholarship.
Cancer genetics to combine forces with nanotechnology to fight breast cancer
MEDIA RELEASE:
04 Oct 2007
Associate Professor Susan Clark, head of Garvan’s Epigenetics Research Group, will play a leading role in a $5 million national research program called "Nanoscaled epigenetic biosensors: How combining two novel technologies will help Advanced Breast Cancer" announced today by the National Breast Cancer Foundation.
Cancer cells suppress large regions of DNA by a reversible process that can be tackled with new therapies
05 Apr 2006
Cancer researchers at Sydney’s Garvan Institute, in collaboration with Spanish scientists, have formulated a new concept for how cancer cells can escape normal growth controls, which may have far-reaching implications for the new generation of cancer therapies.
PM opens ACRF Unit for Molecular Genetics of Cancer at Garvan on May 16 2005
16 May 2005
Prime Minister opens ACRF Unit for Molecular Genetics of Cancer at Garvan
